{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:13:42Z","timestamp":1786115622030,"version":"build-2736575974"},"reference-count":61,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T00:00:00Z","timestamp":1785628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5P30EY001792-27"],"award-info":[{"award-number":["5P30EY001792-27"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"award":["5P30EY001792-27"],"award-info":[{"award-number":["5P30EY001792-27"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["Unrestricted"],"award-info":[{"award-number":["Unrestricted"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"award":["Unrestricted"],"award-info":[{"award-number":["Unrestricted"]}],"id":[{"id":"https:\/\/ror.org\/04drjs621","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Vaccine-associated anterior uveitis (VAAU) is an uncommon ocular inflammatory phenotype reported after several vaccine platforms. It describes anterior segment inflammation occurring after vaccination when infectious, autoimmune, idiopathic, medication-related, and other possible causes have been reasonably excluded. The current literature indicates that post-vaccination uveitis is rare relative to the scale of immunization, although anterior uveitis is frequently reported among post-vaccination ocular inflammatory events. Evidence remains limited by reliance on case reports, case series, retrospective cohorts, and passive surveillance data, which restricts precise incidence estimation and causal interpretation. Accordingly, the available evidence primarily supports a temporal association rather than a confirmed causal relationship. Proposed mechanisms include innate immune activation, molecular mimicry, adjuvant- or formulation-related immune stimulation, bystander activation, delayed-type hypersensitivity, and host susceptibility related to prior uveitis, autoimmune disease, immune dysregulation, or genetic predisposition. Clinically, VAAU may present with redness, pain, photophobia, blurred vision, anterior chamber cells and flare, keratic precipitates, posterior synechiae, elevated intraocular pressure, vitritis, or cystoid macular edema. Most cases described in the literature are mild to moderate and improve with topical corticosteroids and cycloplegic therapy, whereas recurrent, severe, or treatment-intensive courses have been reported mainly in predisposed individuals. Future work should emphasize active surveillance, standardized phenotype-specific reporting, harmonized case definitions, and mechanistic studies to better define risk, recurrence patterns, and causality. Careful interpretation of suspected cases can support accurate diagnosis, patient counseling, and vaccine-safety monitoring without undermining clinically indicated immunization.<\/jats:p>","DOI":"10.3390\/vaccines14080672","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:57:56Z","timestamp":1785761876000},"page":"672","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vaccine-Associated Anterior Uveitis"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6768-2830","authenticated-orcid":false,"given":"Seyyedehfatemeh","family":"Ghalibafan","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Illinois Chicago, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Oraei","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Illinois Chicago, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadali","family":"Ashraf","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Illinois Chicago, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali R.","family":"Djalilian","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Illinois Chicago, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Bhat","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Illinois Chicago, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7385-6534","authenticated-orcid":false,"given":"Hajirah N.","family":"Saeed","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Illinois Chicago, Chicago, IL 60612, USA"},{"name":"Department of Ophthalmology, Loyola University Medical Center, Maywood, IL 60153, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/S0140-6736(24)00850-X","article-title":"Contribution of vaccination to improved survival and health: Modelling 50 years of the Expanded Programme on Immunization","volume":"403","author":"Shattock","year":"2024","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Okuyama, R. (2023). mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions. Vaccines, 11.","DOI":"10.3390\/vaccines11121737"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1111\/bcp.14112","article-title":"Immune-mediated adverse reactions to vaccines","volume":"85","author":"Stone","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_4","unstructured":"U.S. Department of Health and Human Services (2026, June 06). Vaccine Adverse Event Reporting System (VAERS), Available online: https:\/\/vaers.hhs.gov\/."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e70747","DOI":"10.1002\/jmv.70747","article-title":"Systematic Review of Postvaccination Ocular Adverse Events: A Comprehensive Analysis of Published Reports","volume":"97","author":"Zou","year":"2025","journal-title":"J. Med. Virol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.survophthal.2021.04.001","article-title":"Ocular adverse events following vaccination: Overview and update","volume":"67","author":"Cheng","year":"2022","journal-title":"Surv. Ophthalmol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcjo.2024.07.013","article-title":"Anterior uveitis for the comprehensive ophthalmologist","volume":"60","author":"Xie","year":"2024","journal-title":"Can. J. Ophthalmol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ophtha.2022.08.027","article-title":"Vaccine-Associated Uveitis after COVID-19 Vaccination","volume":"130","author":"Singh","year":"2022","journal-title":"Ophthalmology"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Ichhpujani, P., Parmar, U.P.S., Duggal, S., and Kumar, S. (2022). COVID-19 Vaccine-Associated Ocular Adverse Effects: An Overview. Vaccines, 10.","DOI":"10.3390\/vaccines10111879"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/bjo-2024-325985","article-title":"Global burden of vaccine-associated uveitis and their related vaccines, 1967\u20132023","volume":"109","author":"Oh","year":"2024","journal-title":"Br. J. Ophthalmol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12348-021-00275-x","article-title":"Ocular inflammatory events following COVID-19 vaccination: A multinational case series","volume":"12","author":"Testi","year":"2022","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1080\/09273948.2022.2042316","article-title":"Anterior Uveitis following COVID Vaccination: A Summary of Cases from Global Reporting Systems","volume":"30","author":"Nanji","year":"2022","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/IAE.0000000000004413","article-title":"THE HETEROGENEOUS PRESENTATIONS OF DE NOVO AND RECURRENT OCULAR INFLAMMATION AFTER COVID-19 VACCINATION","volume":"45","author":"Arepalli","year":"2025","journal-title":"Retina"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/09286586.2024.2343714","article-title":"Incidence and Association of Uveitis with COVID-19 Vaccination: A Systematic Review and Meta-Analysis","volume":"32","author":"Padhi","year":"2024","journal-title":"Ophthalmic Epidemiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"8766021","DOI":"10.1155\/jimr\/8766021","article-title":"A Systematic Review of Ocular Complications Following Different Types of COVID-19 Vaccines","volume":"2025","author":"Ebrahimi","year":"2025","journal-title":"J. Immunol. Res."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Shemer, A., Toledano, A., Altarescu, A., Dubinsky-Pertzov, B., Rozenberg, A., Hecht, I., Einan-Lifshitz, A., and Pras, E. (2025). COVID-19 Vaccination and Acute Anterior Uveitis\u2014A Case Control Study. Vaccines, 13.","DOI":"10.3390\/vaccines13020176"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ophtha.2022.05.015","article-title":"Association between Vaccination with the BNT162b2 mRNA Coronavirus Disease 2019 Vaccine and Noninfectious Uveitis","volume":"129","author":"Sar","year":"2022","journal-title":"Ophthalmology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.ophtha.2023.07.017","article-title":"Risk of Noninfectious Uveitis after Coronavirus Disease 2019 Vaccination in a United States Claims Database","volume":"130","author":"Kumar","year":"2023","journal-title":"Ophthalmology"},{"key":"ref_19","first-page":"125","article-title":"Uveitis Risk After the First Dose of COVID-19 Vaccination Based on Uveitis History: Matched Cohort and Crossover Case Series Study","volume":"262","author":"Kim","year":"2024","journal-title":"Arch. Ophthalmol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/jamaophthalmol.2024.0973","article-title":"COVID-19 Vaccine\u2013Associated Uveitis in Patients With a History of Uveitis","volume":"142","author":"Kim","year":"2024","journal-title":"JAMA Ophthalmol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bjo-2023-324503","article-title":"Ocular inflammatory events following COVID-19 vaccination: Reporting of suspected adverse drug reactions to regulatory authorities in the UK","volume":"108","author":"Testi","year":"2023","journal-title":"Br. J. Ophthalmol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","article-title":"Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)","volume":"33","author":"Shimabukuro","year":"2015","journal-title":"Vaccine"},{"key":"ref_23","first-page":"48","article-title":"Vaccine-Associated Uveitis","volume":"113","author":"Benage","year":"2016","journal-title":"Mo. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/09273948.2019.1626188","article-title":"Vaccine-Associated Uveitis","volume":"27","author":"Cunningham","year":"2018","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zou, Y., Kamoi, K., Zong, Y., Zhang, J., Yang, M., and Ohno-Matsui, K. (2023). Ocular Inflammation Post-Vaccination. Vaccines, 11.","DOI":"10.3390\/vaccines11101626"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e247578","DOI":"10.1136\/bcr-2021-247578","article-title":"Papillitis and uveitis complicating Bacillus Calmette-Gu\u00e9rin immunotherapy","volume":"15","author":"Toohey","year":"2022","journal-title":"BMJ Case Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/09273948.2014.925126","article-title":"Rubella Virus-associated Anterior Uveitis in a Vaccinated Patient: A Case Report","volume":"24","author":"Berge","year":"2014","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"104265","DOI":"10.1016\/j.jfo.2024.104265","article-title":"Uveitis following COVID-19 vaccination in the pediatric population: Experience at a tertiary referral hospital","volume":"47","author":"Alsalman","year":"2024","journal-title":"J. Fran\u00e7ais d\u2019Ophtalmol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1080\/09273948.2023.2200858","article-title":"COVID Vaccine-Associated Uveitis","volume":"31","author":"Neri","year":"2023","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2138051","DOI":"10.1080\/21645515.2022.2138051","article-title":"Inflammatory ocular events after inactivated COVID-19 vaccination","volume":"18","author":"Fei","year":"2022","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s10384-022-00962-9","article-title":"A multicenter study of ocular inflammation after COVID-19 vaccination","volume":"67","author":"Yasaka","year":"2022","journal-title":"Jpn. J. Ophthalmol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1007\/s10792-023-02684-4","article-title":"Intraocular inflammation following COVID-19 vaccination: The clinical presentations","volume":"43","author":"Li","year":"2023","journal-title":"Int. Ophthalmol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00417-022-05798-0","article-title":"New onset of acute uveitis following COVID-19 vaccination","volume":"261","author":"Sim","year":"2022","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40794-023-00205-w","article-title":"Ocular manifestations and diagnosis of tuberculosis involving the uvea: A case series","volume":"9","author":"Tsui","year":"2023","journal-title":"Trop. Dis. Travel Med. Vaccines"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Kim, J., and Ahn, S.J. (2024). Risk of Post-COVID-19 Uveitis and Risk Modification by Vaccination: A Nationwide Retrospective Cohort Study. Vaccines, 12.","DOI":"10.2139\/ssrn.4819269"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Ott, M., Nagamany, T., Zandi, S., Pichi, F., Agarwal, A., Carre\u00f1o, E., Gupta, V., Grewal, D.S., Cunningham, E.T., and Munk, M.R. (2023). Herpetic anterior uveitis following COVID-19 vaccines: A case series. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1242225"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1080\/09273948.2022.2055580","article-title":"Herpes Simplex Virus 1 Anterior Uveitis following Coronavirus Disease 2019 (COVID-19) Vaccination in an Asian Indian Female","volume":"30","author":"Sangoram","year":"2022","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.4103\/IJO.IJO_2942_22","article-title":"Pole-to-pole involvement of varicella zoster virus reactivation following COVID-19 vaccination","volume":"71","author":"Mahendradas","year":"2023","journal-title":"Indian. J. Ophthalmol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Han, J., Harper, J., Copland, D.A., and Maghsoudlou, P. (2026). The Immunopathogenesis of uveitis. Front. Med., 13.","DOI":"10.3389\/fmed.2026.1717056"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Wakefield, D., Clarke, D., and McCluskey, P. (2021). Recent Developments in HLA B27 Anterior Uveitis. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.608134"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Zou, Y., Kamoi, K., Zong, Y., Zhang, J., Yang, M., and Ohno-Matsui, K. (2024). Vaccines and the Eye: Current Understanding of the Molecular and Immunological Effects of Vaccination on the Eye. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25094755"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","article-title":"Innate immune mechanisms of mRNA vaccines","volume":"55","author":"Verbeke","year":"2022","journal-title":"Immunity"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Wildner, G., and Diedrichs-M\u00f6hring, M. (2020). Molecular Mimicry and Uveitis. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.580636"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"104472","DOI":"10.1016\/j.amsu.2022.104472","article-title":"SARS-CoV-2 vaccination and uveitis: Are they linked?","volume":"81","author":"Waseem","year":"2022","journal-title":"Ann. Med. Surg."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12348-023-00358-x","article-title":"Ocular manifestations following COVID-19 vaccination","volume":"13","author":"Mahendradas","year":"2023","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"ref_46","first-page":"582211","article-title":"Anterior Uveitis in an HLA-B27 Positive Patient Following Influenza Vaccination","volume":"19","author":"Pan","year":"2026","journal-title":"Int. Med. Case Rep. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e67396","DOI":"10.7554\/eLife.67396","article-title":"Intraocular dendritic cells characterize HLA-B27-associated acute anterior uveitis","volume":"10","author":"Kasper","year":"2021","journal-title":"eLife"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1080\/09273948.2025.2530131","article-title":"Anterior Uveitis Associated with ASIA Syndrome: A Distinct Clinical Entity?","volume":"33","author":"Kakil","year":"2025","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1080\/09273948.2023.2220782","article-title":"Ocular Inflammatory Events Following COVID-19 Vaccination in the Paediatric Population: A Multinational Case Series","volume":"32","author":"Testi","year":"2023","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12348-024-00415-z","article-title":"Paediatric Uveitis\u2014The uniqueness in clinical presentation and the efficacy of biologics treatment","volume":"14","author":"Yiu","year":"2024","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Lin, C.-Y., and Chien, H.-J. (2023). Acute exacerbation of ocular graft-versus-host disease and anterior uveitis after COVID-19 vaccination. BMC Ophthalmol., 23.","DOI":"10.1186\/s12886-023-03103-z"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.survophthal.2025.09.021","article-title":"Isolated tattoo-associated uveitis without systemic sarcoidosis: A systematic review of case reports","volume":"71","author":"Ghalibafan","year":"2025","journal-title":"Surv. Ophthalmol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.4103\/ijo.IJO_928_20","article-title":"Viral anterior uveitis","volume":"68","author":"Babu","year":"2020","journal-title":"Indian J. Ophthalmol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ophtha.2017.11.017","article-title":"Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis","volume":"125","author":"Dick","year":"2018","journal-title":"Ophthalmology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3129\/i10-081","article-title":"Practical approach to the use of corticosteroids in patients with uveitis","volume":"45","author":"Cunningham","year":"2010","journal-title":"Can. J. Ophthalmol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"127900","DOI":"10.1016\/j.vaccine.2025.127900","article-title":"Ocular manifestations of vaccine-preventable diseases: A comprehensive review","volume":"68","author":"McCarthy","year":"2025","journal-title":"Vaccine"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12348-025-00527-0","article-title":"Long COVID and the development of new-onset uveitis: A large database study","volume":"15","author":"Dihan","year":"2025","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.4103\/ijo.IJO_2064_22","article-title":"COVID-19 vaccination, dengue hepatitis, and recurrent unilateral anterior uveitis","volume":"71","author":"Sanjay","year":"2023","journal-title":"Indian J. Ophthalmol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"102925","DOI":"10.1016\/j.jaut.2022.102925","article-title":"Risk for uveitis relapse after COVID-19 vaccination","volume":"133","author":"Zhong","year":"2022","journal-title":"J. Autoimmun."},{"key":"ref_60","first-page":"96","article-title":"Development of Classification Criteria for the Uveitides","volume":"228","author":"Jabs","year":"2021","journal-title":"Arch. Ophthalmol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am. J. Ophthalmol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/8\/672\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T04:18:21Z","timestamp":1785989901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/8\/672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,2]]},"references-count":61,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["vaccines14080672"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14080672","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,2]]}}}